• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/10

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

10 Cards in this Set

  • Front
  • Back
Lichen planus:

5 other clinically similar diseases?
Lichen Causes Freaking LAG

1) Lichenoid contact stomatitis
2) Contact stomatitis
3) Foreign body reactions
4) Lupus
5) Allergic mucosal reaction
6) Graft versus host disease
Lichen planus:

1) Site?
2) Clinical features?
3) 2 types?
4) Does LP have malignant potential?
1) Skin, oral mucosa
2) 4 P's - purple, pruritic, polygonal, papules. Interlacing white lines, lace-like reticular pattern (Wickham's striae)
3) Reticular LP, erosive LP
4) Controversial - likely erosive LP if anything. This is why it's *important to do a periodic re-evaluation*
Reticular Lichen Planus:

1) What is more common, reticular or erosive?
2) Site?
3) What does it look like?
4) How do lesions occur?
5) Treatment?
1) Reticular
2) Any oral site - posterior buccal mucosa (bilateral)
3) Interlacing white lines (Wickham's striae), white papules. Dorsal tongue - white plaques
4) Flare up - wax and wane
5) Periodic re-evaluation every year
Erosive lichen planus:

1) Usually ___
2) Clinical appearance?
3) Treatment?
1) Symptomatic
2) Atrophic, erythematous patches (erosion) +/- ulceration. Interlacing white lines (reticulations) at periphery. Gingiva - desquamative gingivitis
3) Corticosteroids (topical > systemic), periodic re-evalu every 3-6 months
Histology of lichen planus? What does IIF/DIF show?
Lichen planus is HP, BH!

1) Hyperkeratosis
2) Pointed "saw-tooth" rete rdiges
3) Band-like layer of lymphocytes
4) Hydropic degeneration

IIF/DIF shows shaggy band of fibrinogen at BMZ
Graft-versus-host-disease:

1) Treatment?
2) 3 sources of stem cells?
3) Indications?
4) Etiology?
5) Occurrence, severity dependent on?
6) What causes the least post-transplant complications?
7) Exceptions?
1) Patient's own autologous stem cells or allogeneic matched donor stem cells infused into patient - infused stem cells reconstitute patient's marrow
2) Bone marrow, peripheral blood, cord blood
3) Hematologic disorders
4) Engrafted donor stem cells attack host cells
5) Histocompatibility HLA match - better match = less severe
6) Find the best HLA match
7) Leukemia - graft-versus-leukemia effect
Graft versus host disease:

1) Incidence?
2) Site of acute GvHD?
3) Site of chronic GvHD?
4) Histology?
5) Treatment?
6) Dental management?
7) BMT patients have an increased risk of?
8) What's necessary?
1) 50% patients receiving allogeneic BMT
2) Skin, GI tract, liver
3) Multiorgan
4) Like lichen planus
5) Prevent through careful matching
6) Same pre-tx recommendations as those undergoing chemo, radiation, IV bisphosphonates
7) Oral epithelial dysplasia, squamous cell ca
8) Periodic re-evaluation
Symptoms of acute graft versus host disease?
1) Skin: maculopapular rash, severe sloughing (burn)
2) GI: Diarrhea, nausea, vomiting, abdominal pain
3) Liver: Early liver dysfunction
Chronic GVHD:

1) Mimics?
2) Symptoms?
3) What does it look like in the oral cavity?
1) Autoimmune diseases
2) Skin - lesions of lichen planus/lupus/systemic sclerosis
GI: Same as acute
Liver: Jaundice, hepatitis, cirrhosis
Eyes: Dryness, Sjogren's
3) ~lichen planus, pyogenic granuloma like lesion
Psoriasis:

1) Etiology?
2) Site?
3) Clinical features?
4) Histology?
5) How to treat severe psoriasis?
6) Increased risk of?
1) Immune-mediated, increased proliferation of skin keratinocytes. Activation of T lymphocytes
2) Skin
3) Well-demarcated, erythematous plaques w/ silver scale, symmetric, periods of exacerbation and remission (winter?). Variable appearance.
4) ~Erythema migrans (ie psoriasiform mucositis), elongated rete ridges, collections of intraepithelial neutrophils (Munro abscesses)
5) TNF-alpha inhibitors, T-cell receptor agents
6) Cutaneous squamous cell carcinoma